RDC Clinical

CompanyAustralia

RDC Clinical develops 2 assets, the furthest in phase 3 (vitamin b12). Mostly supplement and small molecule acting on lipid and ceramide metabolism, PPARA and inflammation; based in Australia.

Assets
2
Furthest
Phase 3
Trials
5
Signals
0

Pipeline

2

  • vitamin b12

    Essential vitamin cofactor involved in cellular metabolism and DNA synthesis.

    Phase 3Supplement

  • palmitoylethanolamide

    Endogenous fatty acid amide acting via PPAR-alpha and endocannabinoid-related pathways to resolve inflammation and neuropathic pain.

    Phase 2Small moleculeLipid and ceramide metabolismPPARAanxietydiabetic peripheral neuropathy

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms5
  • Trials5
  • Signals3
  • Similar companies6

Updated 7 Oct 2026 · 15 sources

Intelligence